These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 19228479)
61. [Few patients with coronary diseases are receiving lipid-lowering therapy]. Stagmo M; Hofman-Bang C; Erhardt L; Rydén L Lakartidningen; 2002 Apr; 99(16):1798-9, 1802-3. PubMed ID: 12043479 [No Abstract] [Full Text] [Related]
62. Cholesterol-lowering drug improves survival after heart transplant. FDA Consum; 2003; 37(1):7-8. PubMed ID: 12625296 [No Abstract] [Full Text] [Related]
63. Understanding IMPROVE-IT and the cardinal role of LDL-C lowering in CVD prevention. Laufs U; Descamps OS; Catapano AL; Packard CJ Eur Heart J; 2014 Aug; 35(30):1996-2000. PubMed ID: 24917645 [No Abstract] [Full Text] [Related]
64. Increased epistaxis with use of ezetimibe/simvastatin. Shah B; McAllister A; Davidson TM Ann Pharmacother; 2009 Sep; 43(9):1545. PubMed ID: 19671801 [No Abstract] [Full Text] [Related]
65. [Innovation instead of imitation -- news in drug therapy -- regarding the contribution in DMW 13/2005]. Thesen R Dtsch Med Wochenschr; 2005 May; 130(20):1280. PubMed ID: 15889335 [No Abstract] [Full Text] [Related]
71. How doubling up drugs saves lives. Why doctors increasingly deploy an array of medications all at once. Heart Advis; 2004 Jun; 7(6):1, 7. PubMed ID: 15233105 [No Abstract] [Full Text] [Related]
72. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia. Masuda D; Nakagawa-Toyama Y; Nakatani K; Inagaki M; Tsubakio-Yamamoto K; Sandoval JC; Ohama T; Nishida M; Ishigami M; Yamashita S Eur J Clin Invest; 2009 Aug; 39(8):689-98. PubMed ID: 19490064 [TBL] [Abstract][Full Text] [Related]
73. Timing of simvastatin treatment: trial is not reported according to CONSORT guidelines. Calvert M; McManus R; MacLeod J BMJ; 2004 Jan; 328(7432):167-8; author reply 168. PubMed ID: 14726360 [No Abstract] [Full Text] [Related]
74. Lipid-lowering therapy in calcific aortic stenosis. Chan KL; Teo K N Engl J Med; 2005 Sep; 353(10):1066-7; author reply 1066-7. PubMed ID: 16148295 [No Abstract] [Full Text] [Related]
75. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial). Grundy SM; Vega GL; Tomassini JE; Tershakovec AM Am J Cardiol; 2009 Aug; 104(4):548-53. PubMed ID: 19660610 [TBL] [Abstract][Full Text] [Related]
76. [Combination pharmacotherapy therapy in the management of atherogenic dyslipidemia]. Kłosiewicz-Latoszek L; Cybulska B Kardiol Pol; 2005 Jun; 62 Suppl 2():II76-80. PubMed ID: 19813341 [No Abstract] [Full Text] [Related]
77. [Reduced levels of lipids and cerebrovascular disease--benefits and risks?]. Olsson JE Lakartidningen; 2002 Apr; 99(17):1967-9. PubMed ID: 12043425 [No Abstract] [Full Text] [Related]
79. Simvastatin and plasma very-long-chain fatty acids in X-linked adrenoleukodystrophy. Verrips A; Willemsen MA; Rubio-Gozalbo E; De Jong J; Smeitink JA Ann Neurol; 2000 Apr; 47(4):552-3. PubMed ID: 10762175 [No Abstract] [Full Text] [Related]
80. [Using simvastatin in combination with chophytol at early stages of cholelithiasis in elderly patients]. Kobylina EIu; Vakhrushev IaM Eksp Klin Gastroenterol; 2008; (5):11-5. PubMed ID: 19148995 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]